Anti-CD19 CAR transduced T-cells/cyclophosphamide/fludarabineCytokine release syndrome: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1833卷 / 1期

关键词：

D O I：

10.1007/s40278-020-86855-8

中图分类号：

学科分类号：

摘要：

引用

页码：37 / 37

共 50 条

[31] Anti-CD19-CAR-transduced-T-cellsCytokine release syndrome-associated coagulopathy: 2 case reports
Reactions Weekly, 2022, 1889 (1) : 31 - 31
[32] Cyclophosphamide/fludarabineCytokine release syndrome, robust tumour lysis syndrome and neurotoxicity: case report
Reactions Weekly, 2018, 1696 (1) : 118 - 118
[33] Anti-CD19-CAR-transduced-T-cellsImmune effector cell-associated neurotoxicity syndrome: case report
Reactions Weekly, 2025, 2049 (1) : 33 - 33
[34] IMMUNOTHERAPY Treatment of aggressive lymphomas with anti-CD19 CAR T cells
Klebanoff, Christopher A.
Yamamoto, Tori N.
Restifo, Nicholas P.
NATURE REVIEWS CLINICAL ONCOLOGY, 2014, 11 (12) : 685 - 686
[35] Anti-CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE
Li, Mengtao
Zhang, Yan
Jiang, Nan
Ning, Chun
Wang, Qian
Xu, Dong
Wang, Ziqian
Lv, Lulu
Zhou, Daobin
Zeng, Xiaofeng
NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (04): : 376 - 378
[36] Anti-CD19-CAR-transduced-T-cells/Fampridine/OcrelizumabCytokine release syndrome, Uhthoff's phenomenon and lack of efficacy
Reactions Weekly, 2024, 2016 (1) : 40 - 40
[37] Anti-CD19-CAR-transduced-T-cells/antineoplasticsVarious toxicities: 2 case reports
Reactions Weekly, 2025, 2056 (1) : 49 - 49
[38] Anti-cd19-car-transduced-t-cells/ibrutinibLack of efficacy: 7 case reports
Reactions Weekly, 2022, 1889 (1) : 32 - 32
[39] Anti-CD19-CAR-transduced-T-cells/sintilimabLack of efficacy: 6 case reports
Reactions Weekly, 2023, 1984 (1) : 53 - 53
[40] Anti-CD19-CAR-transduced-T-cells/pembrolizumabVarious toxicities: 3 case reports
Reactions Weekly, 2020, 1802 (1) : 37 - 37

← 1 2 3 4 5 →